APA

van Marrewijk C. J., Mujakovic S., Fransen G. A. J., Numans M. E., de Wit N. J., Muris J. W. M., van Oijen M. G. H., Jansen J. B. M. J., Grobbee D. E., Knottnerus J. A. & Laheij R. J. F. (20090130). Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial. : Lancet (London, England).

Chicago

van Marrewijk Corine J, Mujakovic Suhreta, Fransen Gerdine A J, Numans Mattijs E, de Wit Niek J, Muris Jean W M, van Oijen Martijn G H, Jansen Jan B M J, Grobbee Diederik E, Knottnerus J André and Laheij Robert J F. 20090130. Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial. : Lancet (London, England).

Harvard

van Marrewijk C. J., Mujakovic S., Fransen G. A. J., Numans M. E., de Wit N. J., Muris J. W. M., van Oijen M. G. H., Jansen J. B. M. J., Grobbee D. E., Knottnerus J. A. and Laheij R. J. F. (20090130). Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial. : Lancet (London, England).

MLA

van Marrewijk Corine J, Mujakovic Suhreta, Fransen Gerdine A J, Numans Mattijs E, de Wit Niek J, Muris Jean W M, van Oijen Martijn G H, Jansen Jan B M J, Grobbee Diederik E, Knottnerus J André and Laheij Robert J F. Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial. : Lancet (London, England). 20090130.